Inflammatory Breast Cancer

Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer, accounting for approximately 1-5% of all breast cancer cases in the United States. Unlike other types, IBC often does not present with a distinct lump but rather manifests with symptoms such as redness, swelling, and warmth in the breast. This rapid onset of symptoms is due to cancer cells blocking lymph vessels in the skin of the breast. Diagnosis requires a biopsy to confirm cancerous cells in the skin or breast tissue. Treatment typically involves a multimodal approach including chemotherapy to shrink the tumor, followed by surgery (mastectomy) and radiation therapy to eliminate remaining cancer cells. Targeted therapies and hormone therapy may also be used based on specific tumor characteristics. Early diagnosis and aggressive treatment are crucial due to the rapid progression of IBC, underscoring the importance of awareness and prompt medical attention.

    Related Conference of Inflammatory Breast Cancer

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    Inflammatory Breast Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in